Agenus AGEN
NASDAQ AGEN
$8.32 +0.09 (+1.03%)
As of: Sep 4, 2026 · 1:37 PM EDT

Agenus (AGEN) Non Operating Income (2010 - 2026)

Agenus (AGEN) posted quarterly Non Operating Income of -$208000.0 for Q1 2026, up 21.21% year-over-year from -$171600.0 in Q1 2025, and up 99.42% quarter-over-quarter from -$35.7 million in Q4 2025.

Analysis

Agenus (AGEN) Non Operating Income (2010 - 2026) Analysis & Trends

Agenus' Non Operating Income history runs 17 years deep, the most recent figure standing at -$208000.0 for Q1 2026.

  • In Q1 2026, Non Operating Income rose 21.21% year-over-year to -$208000.0; the TTM figure through Mar 2026 stood at -$55.2 million (up 71.15% YoY), while the FY2025 annual figure was -$55.3 million, up 53.01% from the prior year.
  • Non Operating Income for Q1 2026 stood at -$208000.0, up from -$35.7 million in the prior quarter.
  • The five-year high for Non Operating Income was $9.1 million in Q2 2022, with the low at -$123.7 million in Q4 2024.
  • The 5-year median for Non Operating Income is -$17.3 million (2022), against an average of -$24.5 million.
  • The sharpest annual moves came in 2022 and 2024: Non Operating Income soared 1084.89% in 2022, then slumped 73765.0% in 2024.
  • Agenus' Non Operating Income stood at -$17.3 million in 2022, then plunged by 466.6% to -$98.2 million in 2023, then decreased by 25.99% to -$123.7 million in 2024, then surged by 71.14% to -$35.7 million in 2025, then jumped by 99.42% to -$208000.0 in 2026.
  • Business Quant data shows AGEN's Non Operating Income at -$208000.0 in Q1 2026, -$35.7 million in Q4 2025, and -$19.3 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn 234.30 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn -
5 Revolution Medicines 44.05 Bn 44.05 Bn - -139.24 Mn
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn -53.64 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - -51.63 Mn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -
10 Agenus 344.35 Mn 344.35 Mn 34.52 Mn 856,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 856,000.00
Mar 31, 2026 -208,000.00
Dec 31, 2025 17.35 Mn
Sep 30, 2025 -19.30 Mn
Jun 30, 2025 -12,000.00
Mar 31, 2025 -264,000.00
Dec 31, 2024 -224,000.00
Sep 30, 2024 19,000.00
Jun 30, 2024 7.14 Mn
Mar 31, 2024 -1.11 Mn
Dec 31, 2023 -201,000.00
Sep 30, 2023 442,000.00
Jun 30, 2023 -244,000.00
Mar 31, 2023 40,000.00
Dec 31, 2022 2.92 Mn
Sep 30, 2022 537,000.00
Jun 30, 2022 9.06 Mn
Mar 31, 2022 56,000.00
Dec 31, 2021 2.99 Mn
Sep 30, 2021 121,000.00